<- Go Home

Euroapi S.A.

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances. It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization. Euroapi S.A. was incorporated in 2020 and is based in Paris, France.

Market Cap

EUR 306.8M

Volume

329.9K

Cash and Equivalents

EUR 73.0M

EBITDA

EUR 48.3M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 142.4M

Profit Margin

15.49%

52 Week High

EUR 4.54

52 Week Low

EUR 2.26

Dividend

N/A

Price / Book Value

0.31

Price / Earnings

-2.33

Price / Tangible Book Value

0.32

Enterprise Value

EUR 302.9M

Enterprise Value / EBITDA

5.51

Operating Income

-EUR 13.1M

Return on Equity

13.67%

Return on Assets

-0.53

Cash and Short Term Investments

EUR 73.0M

Debt

EUR 69.1M

Equity

EUR 983.5M

Revenue

EUR 919.2M

Unlevered FCF

EUR 132.2M

Sector

Pharmaceuticals

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches